matiim

The next insight

Case Studies

Our case studies show how we work with clients to tackle the complexities of pharma, life sciences, and other industries. We focus on turning intelligence into real, measurable outcomes—whether that means mapping competitive pipelines, tracking regulatory changes, guiding market entry, or uncovering consumer trends. Each project brings together deep research, primary insights, and industry expertise to help clarify tough decisions, anticipate competitive and regulatory shifts, and shape pricing, reimbursement, and go-to-market strategies. With a mix of global reach and strong local perspectives, we give decision-makers the clarity and confidence to move quickly and act with precision.

Geography of Interest: US and EU

Management Challenge

The client wants to assess clinician perceptions of four investigational and marketed therapies (A, B, C, and D) in pulmonary arterial hypertension (PAH), focusing on:

  • Differentiation by efficacy, safety, MoA, administration, and endpoints
  • Market adoption potential and 5-year share forecasts
  • Switching thresholds from current standards (safety trade-offs, storage, logistics)

Approach

Matiim conducted in-depth interviews with PAH specialists using a structured guide to explore:

  • Product preference & best-in-class selection (efficacy vs. safety)
  • Market adoption forecasts and share estimates
  • MoA differentiation (TGF-β inhibition, activin signaling, BMP sparing, enzyme inhibition)
  • Key clinical endpoints (6MWD, PVR, cardiac output, composite risk measures)
  • Impact of administration (cold-chain, inhaled vs. systemic delivery)
  • Safety vs. efficacy trade-offs influencing switching

Value Delivered

Product Differentiation

  • Product A: Current leader (robust efficacy, manageable safety), but dosing/bleeding concerns
  • Products B & C: Strong safety, BMP sparing, but need late-stage validation
  • Product D: Inhaled convenience, but weaker safety vs. A–C

Market Forecast

  • A expected to retain ~50% share
  • B & C adoption dependent on pivotal trial results
  • D positioned as niche due to delivery advantage

Strategic Insights

  • Composite endpoints beyond 6MWD will drive adoption
  • Cardiac output gains & reduced bleeding risk are key levers for switching
  • Cold-chain logistics seen as manageable, influencing treatment settings

Commercial Impact

  • Early evidence of physician preference hierarchy
  • Supports pipeline positioning, portfolio strategy, and competitive response
Geography of Interest: China

Management Challenge

An EU-based client sought clarity on the commercialization pathway for Rekovelle in China. Although marketing approval was granted in May 2024, the product has not yet launched. The client wanted insights on launch timelines, pricing strategy, hospital/center targeting, field force deployment, and NRDL inclusion prospects to inform its own China expansion strategy in reproductive medicine.

Approach

Matiim conducted primary CI interviews with stakeholders involved in Ferring’s Rekovelle launch preparation in China. Key lines of investigation included:

  • Launch Timing & Delays: Verified approval status, local partner collaboration, and reasons for manufacturing/logistics delays.
  • Pricing Strategy: Benchmarked Rekovelle vs. Gonal-F and other FSH analogs; clarified pricing unit (per microgram via prefilled pen).
  • Market Access: Probed on NRDL prospects, timing of negotiations, and interim reliance on commercial insurance.
  • Supply Constraints: Assessed anticipated shortages post-NRDL inclusion and mitigation strategies.
  • Commercial Deployment: Captured field force build-up plans (100–150 reps) and alignment with IVF centers and specialty clinics.
  • Target Institutions: Mapped prioritization strategy (leading fertility hospitals and IVF centers in tier-1 cities, gradual expansion to tier-2/3).

Value Delivered

  • Launch Forecasting: Identified expected availability in mid-to-late 2025, with delays due to supply and logistics challenges.
  • Pricing Insight: Confirmed premium positioning with pricing per microgram, maintaining differentiation vs. other FSH products.
  • Access Outlook: Clarified that NRDL inclusion will require 1–2 negotiation cycles, as ART therapies were excluded in 2024.
  • Risk Mitigation: Highlighted Ferring’s reliance on commercial insurance partnerships and supply chain acceleration to offset access risks.
  • Commercial Model: Validated 100–150 reps expected for promotion via local partner collaborations, initially focused on specialized IVF centers in major cities.
  • Strategic Guidance: Equipped the EU client with actionable benchmarks on launch timelines, access hurdles, and field-force strategy to shape its own reproductive medicine expansion in China.
Geography of Interest: China

Management Challenge

A US-based client sought competitive visibility into’ CCR8 antibody LM-108, following pooled Phase I/II results presented at ASCO 2024. The client’s objective was to understand LaNova’s development progress, trial design outlook, competitive positioning, and China-centric strategy to inform its own immuno-oncology planning.

Approach

Matiim conducted primary CI interviews and secondary analysis of LaNova’s clinical development updates:

  • Clinical Progress: Assessed pooled data from three Phase I/II trials (China, US, Australia) of LM-108 in gastric cancer, with combination anti–PD-1 therapy showing encouraging efficacy and safety.
  • Phase III Readiness: Probed timeline expectations, revealing that pivotal trials are likely to initiate in H2 2025, with indications that the program may be China-restricted rather than global.
  • Trial Design Indicators: While details remain undisclosed, insights suggested Phase III will hinge on ongoing data strength, with endpoints expected to align with OS/PFS and anti–PD-1 comparators.
  • Indication Expansion: Verified pipeline prioritization beyond gastric cancer into NSCLC and TNBC, with potential future exploration in gastroesophageal and colorectal cancers.
  • Differentiation Strategy: Evaluated LM-108’s mechanism (TITR depletion), safety profile (no dose-limiting toxicities), and competitive positioning vs. other CCR8-targeted antibodies.

Value Delivered

  • Launch Outlook: Clarified Phase III initiation plan in H2 2025, with China as the primary geography.
  • Pipeline Breadth: Identified NSCLC and TNBC as near-term expansion areas, supporting multi-indication potential.
  • Competitive Edge: Positioned LM-108 as differentiated due to unique MoA, favorable safety profile, and combinability with PD-1 inhibitors.
  • Strategic Signals: Highlighted reliance on partnership discussions to progress to Phase III, suggesting potential BD&L entry points for competitors.
  • Actionable Benchmarking: Equipped the US client with insight into China’s CCR8 development trajectory, timelines, and differentiation claims, enabling strategic planning for portfolio positioning and collaboration opportunities.
Geography of Interest: Global

Management Challenge

A biopharma client sought early clarity on Merck’s first-line KRAS G12C strategy, specifically the design and impact of the upcoming phase-3 trial. Key challenges included:

  • Limited visibility into trial design and endpoints prior to protocol release
  • Uncertainty on patient eligibility and enrollment timelines
  • Competitive benchmarking vs. Adagrasib, Sotorasib, and PD-1 monotherapy
  • Need for early insights to guide portfolio and launch planning

Approach

Matiim conducted targeted primary research with respondents close to the trial planning process. Focus areas included:

  • Trial objectives, design parameters, timelines, and patient scope
  • Probes on Merck’s positioning (e.g., prior SOC cycles, endpoint selection)
  • Competitive context through cross-referencing other KRAS G12C programs
  • Identifying gaps to avoid over-interpretation (e.g., internal PD-L1-negative data)

Value Delivered

Trial Structure: >500 patients; co-primary endpoints of PFS & OS; direct randomization with no prior systemic therapy

Strategic Foresight: Merck aiming for broad label, independent of PD-L1 status

Operational Intelligence: Enrollment design clarified; no SOC cycles permitted pre-randomization

Decision Support:

  • Benchmarked Merck vs. competing KRAS G12C programs
  • Forecasted trial timelines and readouts
  • Anticipated disruption to PD-1 and KRAS G12C treatment landscape
Geography of Interest: Japan

Management Challenge

A leading global pharmaceutical company sought to understand competitive positioning, field-force messaging, and future combination therapy strategies in the highly competitive Type II diabetes market. With multiple DPP-4 inhibitors (QD/BID and once-weekly) and SGLT2 inhibitors launched across Japan and global markets, the client needed actionable insights on detailing practices, counter-detailing strategies, and patient targeting dynamics to refine its commercial strategy.

Approach

Matiim conducted 15+ interviews/discussion with Japanese stakeholder starting from reps, medical affairs, local distributors and gather the insights around the KIQs

  • Analyzed messaging, positioning, and counter-detailing tactics for linagliptin (Trazenta), saxagliptin (Onglyza), sitagliptin (Januvia), and alogliptin (Nesina).
  • Assessed pipeline developments for fixed-dose combinations (FDCs) with metformin, including Takeda’s alogliptin/metformin submission in Japan, with dose strengths verified.
  • Reviewed launch strategies and positioning of trelagliptin (Zafatek) and omarigliptin (Marizev).
  • Conducted field insights on whether Takeda reps detail both Nesina & Zafatek and MSD reps detail both Januvia & Marizev.
  • Mapped patient targeting differences between once-weekly vs once/twice-daily DPP-4 inhibitors, highlighting physician adoption drivers.
  • Benchmarked detailing and positioning of empagliflozin (Jardiance), dapagliflozin (Forxiga), ipragliflozin (Suglat), canagliflozin (Canaglu), and tofogliflozin (Deberza/Apleway).
  • Evaluated whether these agents are being positioned primarily as 2nd-line therapies or relegated to 3rd-line use, with implications for patient uptake and treatment sequencing.

Value Delivered

  • Delivered a comprehensive competitor detailing matrix across DPP-4 and SGLT2 classes.
  • Provided clarity on messaging overlaps, counter-detailing practices, and rep deployment strategies across Takeda, MSD, AZ, BI/Lilly, and others.
  • Identified combination therapy opportunities (especially metformin FDCs) with potential to strengthen market differentiation.
  • Mapped treatment-line positioning trends to support client’s strategy for brand messaging, patient segmentation, and future launch preparedness.
  • Outcome: The client gained a 360° view of competitive field activities and positioning dynamics, enabling refined commercial planning, physician engagement strategy, and competitive counter-messaging in the Japanese Type II diabetes market.
Geography of Interest: Middle East

Management Challenge

A UK-based global nutraceutical company engaged Matiim to understand the Middle East market, identify growth opportunities, and explore potential collaborations for portfolio expansion.

Approach

  • Conducted desk research to build a detailed market overview, competitive landscape, and regulatory analysis
  • Carried out structured interviews with pharma and nutraceutical executives to validate findings and assess licensing positions
  • Evaluated potential partners on multiple parameters to identify the best-fit candidates for collaboration

Value Delivered

  • Delivered a shortlist of target companies for in-licensing opportunities
  • Provided actionable intelligence on market entry, regulatory considerations, and partnership strategies to strengthen regional presence
Geography of Interest: India

Management Challenge

Based on prior consumer research findings, the client engaged Matiim to evaluate prescription habits of general practitioners (GPs) and diabetologists for sugar-free and artificial sweeteners. The objective was to assess how frequently these products were being recommended in clinical practice and to understand the strength of brand recall within this therapeutic category. The study focused on key metropolitan and regional markets across India, including Kolkata, Cuttack, Delhi, Lucknow, Mumbai, Pune, Ahmedabad, Hyderabad, Bangalore, and Chennai.

Approach

Matiim designed and executed a structured primary research program combining multiple methodologies to ensure both breadth and depth of insights:

  • Online Surveys: Captured quantitative measures of prescription frequency and product preferences.
  • Telephonic Interviews: Explored deeper perceptions, rationale for prescribing, and patient feedback loops.
  • CATI/CAWI (Computer-Assisted Telephonic/Web Interviews): Ensured standardized data collection across geographies, reducing bias and improving comparability.
  • The survey instrument covered areas such as brand awareness, prescribing triggers (safety, taste, patient demand), and competitive benchmarking of leading artificial sweetener brands.

Value Delivered

  • Brand Usage Measurement: Quantified the extent of brand penetration within physician prescriptions and identified which products dominate in awareness and adoption.
  • Brand Recall Insights: Evaluated spontaneous and aided recall, providing an indication of the ease with which a brand comes to mind for prescribers.
  • Actionable Intelligence: Equipped the client with granular, city-level insights into prescribing behavior and brand perception, helping refine marketing strategy, physician engagement, and competitive positioning.
  • Impact: The study provided the client with a clear roadmap for strengthening brand equity—highlighting both strongholds and white spaces—while aligning promotional strategies with prescriber behaviors and market readiness.
Geography of Interest: US, Russia and Brazil

Management Challenge

A US based client with portfolio in pain management was interested to license one of PEMF based pain management device (The device of interest was already had regulatory approval in more than 60 countries for different type of pain management) from a medical device manufacture. The client was interested to know the OTC regulatory approval assessment of the device in US, Russia and Brazilian market where client was active

Approach

Matiim Developed an understanding of science of the medical devices based on proposed therapies in pain management devices such TENS,  PEMF, ultrasonic or light-based therapies

  • Developed an understanding of medical devices approval process in geographies of interest
  • Understood the regulatory scenario of such therapies in US Russia and Brazil
  • Listed down the key products in each therapy segment (predicate device) and understood their regulatory classification and approval status
  • Understood the labeling and other regulatory requirement of such devices
  • Understand the clinical studies conducted in each product & therapy class and understood the medical device classification of such devices
  • Connected with many regulatory experts in US, Russia and Brazil and asked for expert advise on device of interest
  • Formulated and provided the key recommendations to client and future course of action

Value Delivered

  • Client was able to understand the current regulatory environment of different classes of therapies in US , Russia & Brazil
  • Able to map the current regulatory challenge s with device of interest which was based on PEMF based therapy
  • Recommended the future of action in terms of supported clinical data, OTC approval assessment , regulatory filing procedure, proposed classification and other challenges
Geography of Interest: Global

Management Challenge

A US based client with portfolio in pain management was interested to expand its portfolio in pan management therapies. The client was primarily interested in  OTC  pain reliving devices, topical creams (Pharmaceutical as well as herbal). The objective behind this exercise was to understand innovative products with clinically proven data, delivery platform and unique claims.

Approach

  • Scanned the OTC medical devices, products such as topical creams, gels and other formulations
  • Assessed the regulatory status, claims , technology involved and clinical data for products and therapy area.
  • Shortlisted key products based on the clinical support data and technology platform involved in.
  • Benchmarked the key products using in-house ranking model based on different parameters such as number of clinical studies, quality of claims, quality of clinical studies, technology involved, price and geographies.
  • Identified top 5 lead potential licensing candidates
  • Contacted with owner of leading products and asked for their interest in licensing

Value Delivered

  • Client was able to understand the landscape of OTC pain relieving products
  • Study provided the top product candidates with proven clinical safety and efficacy data, quality of claims and technology platforms
  • Client was able to identify the most relevant key products, and their owners for further licensing and alliance.
Geography of Interest: UK

Management Challenge

A global healthcare client sought a comprehensive view of the UK PoC diagnostics market to inform partnering/investment.

  • Required a top-down global context (size, growth, segments, players) and a deep dive on the UK (market dynamics, clinical & competitive landscape).
  • Emphasis on SME/early-stage companies (incl. spinouts and recently funded firms) with infectious-disease focus.
  • Deliverables to include 10 one-page company profiles, and exit analysis (M&A, trade buys, IPOs).

Approach

  • Market Sizing & Segmentation (Global → UK): Built TAM/SAM/SOM using public filings, analyst reports, and NHS procurement data; segmented by setting (home/retail, primary care, acute), modality (lateral flow, molecular/NAAT, digital), and disease area (ID, cardiometabolic, oncology, women’s health).
  • Clinical & Competitive Landscape (UK): Mapped guideline/use-case alignment (NICE, UKHSA), reimbursement & adoption levers, and procurement pathways; benchmarked performance claims vs. clinical evidence and real-world evaluations (e.g., PHE/UKHSA validation programs).
  • Company Universe & Shortlisting: Identified large, SME, and early-stage players (spinouts from TTOs, recently funded). Applied screens: technology maturity (TRL), regulatory status (CE/UKCA/IVDR), manufacturing readiness, route to market, and NHS pilots.
  • Scorecard (Infectious Diseases–Weighted): Scored candidates on 1) clinical utility/sensitivity-specificity, 2) time-to-result & workflow fit, 3) cost-per-test & CoGs trajectory, 4) regulatory/compliance, 5) supply-chain scalability, 6) data/digital integration, 7) IP strength & defensibility, 8) funding runway/partners.
  • 10 One-Page Profiles: For prioritized SMEs: snapshot of financials/funding, team & origin (TTO/spinout), platform & products, target diseases, evidence & pilots, regulatory path, commercial model, risks & catalysts.
  • Exit Tracker: Compiled UK/EU/US PoC exits (last 7–10 yrs) by modality, stage, acquirer type, multiples where available; analyzed patterns (e.g., platform vs. single-assay premiums), and timing from first clinical to exit.
  • Primary CI Touchpoints: Interviews with NHS procurement leads, UK KOLs in ID/primary care, former regulators, and industry operators to validate price corridors, evaluation bottlenecks, and partnership appetite.

Value Delivered

  • UK PoC Market Map: Clear view of demand pockets (primary care/urgent care, community testing, pharmacy), growth drivers (AMR stewardship, winter ID burden, remote monitoring) and constraints (IVDR/UKCA transition, reimbursement clarity).
  • SME/Spinout Shortlist: Ranked list of 10 high-potential UK SMEs/early-stage firms with infectious-disease bias; each with a decision-ready one-pager and go/no-go rationale.
  • Partnering/Investment Pipeline: Identified near-term pilot partners (ICSs, NHS Trusts, retail pharmacy chains) and strategic acquirers by modality; mapped likely co-development and distribution pathways.
  • Financial & Exit Signals: Benchmarked valuation ranges and exit routes (M&A vs. IPO) with modality-specific takeaways to calibrate term sheets and deal timing.
  • Actionable Roadmap: 12-month plan covering evidence generation (health-economic endpoints), regulatory milestones (UKCA/IVDR), procurement engagement, and pricing strategy—de-risking UK entry and accelerating commercialization.
Geography of Interest: Global

Management Challenge

A UK-based consumer health company was interested to know the commercialized, under development and research solutions for color change technologies for one of their key brands, which can improve consumer experience and engagement.

Approach

Market & Technology Scan: Mapped global solutions for color change technologies across three stages — commercialized, under development, and research.

Competitive Benchmarking: Profiled leading players, emerging innovators, and niche technology developers with relevance to consumer health.

Evaluation Framework: Assessed opportunities based on two core criteria:

  • Attractiveness of opportunity (market potential, differentiation, scalability).
  • Fit with client’s infrastructure & objectives (synergy, feasibility, alignment with brand strategy).

Shortlisting Process: Applied a structured scoring model to filter and prioritize companies.

Strategic Mapping: Positioned shortlisted targets by strategic focus (geography, end-use segment, technology).

M&A/Partnership Pathways: Outlined scenarios including potential game-changing merger opportunities and collaboration models.

Value Delivered

Matiim recommended a final selection of five preferred target companies for the client’s consideration, balancing the criteria of

(a) Attractiveness of the opportunity

(b) Fit with the client’s current infrastructure and objectives.

Each of these five opportunities represented a different strategic focus, e.g. geographic vs. end-use segment vs. technology, and a proposal for a game-changing merger with the potential to transform the landscape into a particular arena

Geography of Interest: US

Management Challenge

A global FMCG client wanted to assess the emerging field of personalized nutrition based on microbiome profiles. The objective was to map the competitive landscape, identify active players, and evaluate their capabilities in collection, testing, and personalized nutrition recommendations.
Key challenges included:

  • Fragmented landscape of start-ups, labs, and researchers at varying stages of commercialization.
  • Lack of clarity on data quality, scalability, and scientific rigor of personalized nutrition solutions.
  • Uncertainty around lab frameworks—whether testing is conducted in-house, outsourced, or via hybrid models.
  • Need for benchmarks on recommendation uniqueness, use of multi-data types, and methodology robustness.

Approach

Matiim conducted a competitive landscape study leveraging both secondary research and CI interviews with stakeholders across the personalized nutrition ecosystem:

Player Mapping: Identified and profiled companies and research groups offering microbiome-based collection, testing, and personalized diet recommendations.

Capability Assessment: Benchmarked players on:

  • Size & quality of microbiome datasets.
  • Number of data types integrated (genomics, metabolomics, lifestyle inputs).
  • Degree of personalization in recommendations.
  • Analytical methodologies (16S rRNA, metagenomics, machine learning-based models).

Lab Framework Analysis: Evaluated whether testing was conducted in-house, outsourced to third-party labs, or hybrid models.

Commercialization Readiness: Assessed pipeline maturity of academic spin-offs vs. established companies.

Value Delivered

Comprehensive Landscape Map: Delivered a structured view of players, from early-stage researchers to commercial solution providers.

Benchmarking Framework: Standardized evaluation criteria across dataset size/quality, personalization level, and analytical methods.

Strategic Insights: Highlighted leaders with robust datasets and validated methodologies, versus emerging players still dependent on outsourcing.

Decision Support: Equipped client with clear visibility on partnership, licensing, and investment opportunities in personalized nutrition technologies.

Future Outlook: Identified white spaces in multi-omics integration and AI-driven personalization as the next wave of competitive differentiation.

Geography of Interest: Global

Management Challenge

A global personal care client wanted to evaluate emerging water-less and water-conserving technologies for potential integration into its product portfolio. The key challenges included:

  • Growing pressure to enhance sustainability in products and processes.
  • Fragmented innovation landscape with start-ups, universities, and corporates driving research across industries.
  • Lack of visibility on commercialized vs. under-development technologies.
  • Need to identify applicable solutions for personal care amidst a wide array of innovations.

Approach

Matiim conducted a technology scouting study using a combination of secondary research and targeted expert discussions:

  • Technology Mapping – Created an overview of commercialized, under-development, and research-stage water-conserving solutions.
  • Product Benchmarking – Assessed existing products leveraging water-less or water-saving technologies across industries.
  • Literature & IP Review – Analyzed scientific articles and patents (last 10 years) to identify key innovations and players.
  • Player Profiling – Compiled a comprehensive list of companies, start-ups, and academic groups with active projects.
  • Capability Assessment – Benchmarked players on technical maturity, scalability, and potential application in personal care.
  • Opportunity Evaluation – Identified short-, mid-, and long-term adoption opportunities.

Value Delivered

Comprehensive Landscape View: Delivered a consolidated map of commercialized, under-development, and research-stage water-conserving technologies.

Strategic Insights: Highlighted best practices and players with the strongest applicability to personal care products.

Innovation Pipeline: Identified emerging opportunities in refill formats, concentrated formulations, and water-free delivery systems.

Decision Support: Equipped client with a clear roadmap for integrating sustainable packaging and formulation practices into its portfolio.

Future Readiness: Enabled the client to anticipate upcoming trends and align R&D with sustainability commitments.

Geography of Interest: Global

Management Challenge

An Italian consumer appliance company sought to strengthen its dishwasher portfolio by exploring new technical solutions that could:

  • Reduce or optimize the use of detergent and/or water
  • Identify disruptive technologies capable of enabling a water-free dishwasher concept
  • The client needed visibility into both commercialized solutions and emerging innovations under development to guide its R&D roadmap and future product strategy.

Approach

Matiim designed and executed a structured technology intelligence study tailored to the client’s requirements:

Requirement Mapping

  • Translated client needs into clear technical criteria for solution scouting.
  • Defined assessment parameters such as feasibility, scalability, and proof-of-concept validation.

Three-Tier Research Framework

  • Market Scan: Reviewed existing products and industries where similar solutions were implemented.
  • Developer Scan: Identified technology developers actively working on sustainable dishwasher solutions.
  • Patent & Literature Analysis: Mined global databases to uncover early-stage technologies with potential future application.

Feasibility & Fit Assessment

  • Analyzed identified technologies against client portfolio requirements.
  • Conducted consultations with technology developers to validate technical claims and understand scalability.

Strategic Evaluation

  • Compared shortlisted solutions across maturity levels (commercial, under development, early stage).
  • Evaluated trade-offs in performance, cost, and integration feasibility.

Value Delivered

Technology Recommendations: Delivered a list of both commercialized and under-development technologies technically suitable for client needs.

Validated Solutions: Filtered only those with existing proof-of-concept studies, ensuring technical credibility.

R&D Acceleration: Equipped the client’s R&D team with actionable intelligence on state-of-the-art innovations, saving significant time and effort in scouting.

Strategic Clarity: Provided a roadmap to evaluate immediate and long-term opportunities for next-generation, water-efficient, and detergent-optimized dishwashers.

Impact: The study enabled the client to focus on high-potential innovations, streamline R&D efforts, and position itself as a frontrunner in sustainable home appliance solutions.

Geography of Interest: Global

Management Challenge

A globally recognized glass manufacturer sought to evaluate opportunities in the rapidly evolving HMI (Human Machine Interface) market, especially within consumer electronics and home appliances. While touch panels (primarily glass-based) dominate today’s market, multiple interface technologies (voice, gesture, advanced touch with integrated displays) are emerging. The client needed to:

  • Understand market and technology trends in HMIs across appliances.
  • Benchmark regional differences between North America and Europe.
  • Assess advanced glass materials and functional innovations entering the HMI space.
  • Identify growth opportunities and validate potential applications in their glass portfolio.

Approach

Matiim executed a market and technology landscape assessment using secondary research, expert consultations, and trend analysis:

  • Technology Mapping: Evaluated HMI types (touch, voice, gesture) across home appliance categories.
  • Market Trends: Assessed overall HMI growth, segment-wise trends, and leaders vs. laggards.
  • Appliance-Specific Analysis: Analyzed HMIs in hot (ovens, ranges), cold (refrigerators), wet (washers/dryers), and small appliances (microwaves, coffee machines).
  • Regional Benchmarking: Compared adoption trends and material preferences in North America vs. Europe.
  • Materials & Technologies: Studied glass and non-glass materials, advanced touch/control panel functionalities, and integrated display innovations.
  • Future Outlook: Compared past, present, and next-generation HMI technologies to highlight the innovation pipeline.

Value Delivered

Comprehensive HMI Landscape: Delivered visibility into current and emerging trends across appliance segments.

Technology Benchmarking: Identified advanced glass-based touch panels and multifunctional control panel opportunities.

Regional Insights: Clarified adoption differences between North America and Europe.

Strategic Roadmap: Equipped the client with actionable intelligence to guide R&D, material investments, and positioning in the home appliance HMI ecosystem.

Future Readiness: Highlighted upcoming trends in combination panels (touch + display) and futuristic materials for competitive differentiation.

Geography of Interest: Global

Management Challenge

A European consumer health company sought to identify and evaluate functional sweeteners at the commercial, research, and patent stages. The objective was to:

  • Explore innovative sweeteners that could reduce calorie content while maintaining taste and safety
  • Assess their regulatory readiness, functional benefits, and scalability
  • Prioritize candidates that could be integrated into the client’s product portfolio and align with long-term strategic growth in the functional food and nutraceutical space

Approach

Matiim executed a comprehensive global technology and market scouting study, structured into the following steps:

Technology Scouting

  • Screened global patent databases, scientific publications, and commercial reports to identify functional sweeteners across different stages of development (commercialized, in research, early-stage patents).

Scientific & Regulatory Assessment

  • Reviewed safety data, clinical trial evidence, and regulatory approval status across key geographies.
  • Evaluated functional attributes such as glycemic index, calorie-reduction potential, and compatibility with food and nutraceutical formulations.

Benchmarking & Ecosystem Mapping

  • Mapped key innovators, including start-ups, academic research groups, and established ingredient companies.
  • Benchmarked technologies on processing requirements, scalability, and commercial maturity.

Prioritization Framework

  • Assessed each candidate on parameters including functionality, feasibility, regulatory pathway, and strategic fit.
  • Shortlisted the most promising sweeteners for potential adoption into the client’s portfolio.

Value Delivered

Portfolio Opportunities: Identified functional sweeteners and substitutes with the highest potential for integration into the client’s product pipeline.

Advanced Processing Insights: Provided intelligence on novel processing techniques that reduce sugar calories while preserving taste and stability.

Strategic Fit Analysis: Highlighted candidates most aligned with the client’s business goals, enabling focused investment decisions.

Actionable Roadmap: Delivered a prioritized shortlist and strategic recommendations to accelerate adoption of next-generation sweeteners.

Impact: The study empowered the client’s R&D and commercial teams to pursue innovation-driven portfolio expansion, reduce dependence on conventional sugar, and strengthen their positioning in the growing functional food and nutraceutical markets.

Geographies of Interest: Global

Management Challenge

A leading European food company sought to conduct a technology landscape study on biomass fermentation of fibrous mycoproteins for the meat-alternative segment. The objective was to identify key participants in this emerging field, including manufacturers and start-ups, and assess the technological advancements shaping the space.

Key requirements included:

  • Identification and assessment of novel technologies developed over the last five years.
  • Mapping of mycoprotein fungi taxonomy being utilized, including specific genera and species relevant to biomass fermentation.

Approach

  • Technology Scouting: Conducted secondary research across scientific journals, patent databases, start-up trackers, and industry reports to identify emerging biomass fermentation technologies.
  • Taxonomy Mapping: Reviewed fungi (mushroom) genus and species used in fibrous mycoprotein production, highlighting strains with high scalability and nutritional benefits.
  • Competitive Benchmarking: Profiled leading manufacturers, start-ups, and research institutions active in the space, assessing their capabilities, partnerships, and commercialization progress.
  • Technology Assessment: Evaluated identified innovations on parameters such as efficiency, scalability, sustainability, and alignment with consumer trends in alternative proteins.
  • Opportunity Mapping: Highlighted potential collaboration, licensing, and investment opportunities with promising players.

Value Delivered

  • Provided the client with a comprehensive overview of the biomass fermentation landscape, including cutting-edge technologies and active players.
  • Delivered taxonomy insights on fungi species relevant to fibrous mycoprotein development, supporting scientific and product development decisions.
  • Identified emerging start-ups and disruptive technologies with potential to enhance the client’s meat-alternative portfolio.
  • Enabled the client to define a strategic roadmap for partnerships, R&D focus areas, and next-step investments in alternative protein technologies.
Geographies of Interest: Global

Management Challenge

A leading food and beverages company wanted to identify and assess non-thermal sterilization technologies that could potentially be integrated into their product processing. The objective was to map technologies at different stages of development, evaluate their feasibility, and identify opportunities that align with the client’s business portfolio.

Approach

  • Comprehensive Research: Conducted secondary research across multiple sources including technology blogs, university publications, scientific literature, research articles, and competitor websites to identify relevant technologies.
  • Technology Assessment: Evaluated each shortlisted technology on key parameters such as scalability, safety, cost-effectiveness, regulatory readiness, and applicability in food and beverages.
  • Benchmarking: Compared and profiled technology developers, start-ups, and research institutions to highlight leaders and innovators in the space.
  • Opportunity Mapping: Identified opportunities for adoption, co-development, or licensing around the most promising technologies.

Value Delivered

  • Provided the client with a clear understanding of all potential non-thermal sterilization technologies across various stages of development (research, pilot, and commercial).
  • Highlighted the most relevant and feasible technologies for integration into their portfolio.
  • Mapped out strategic opportunities within the domain, enabling the client to evaluate investment or collaboration options.
  • Supported the client in making informed decisions on next steps toward adopting non-thermal sterilization technologies for product processing.
Geographies of Interest: Global

Management Challenge

A UK-based energy solutions company was interested in identifying technologies and methods capable of generating a micro-porous and hydrophobic metallic surface that can withstand alkaline environments.

The specific requirements included technologies that:

  • Are compatible with or adaptable to metallic substrates, primarily Nickel.
  • Demonstrate hydrophobic properties in the end application (e.g., contact angle).
  • Deliver nano- to micro-porous surfaces with an aperture range of 5–10 microns.
  • Are permeable to gases but not liquids (aqueous solutions).
  • Are scalable to m² size applications.
  • Maintain electrical conductivity.
  • Can withstand hot, strongly alkaline environments.

Approach

Developed a clear understanding of the technical requirements and devised a structured research strategy.

Divided the research into three key segments:

  • Industry Scan: Reviewed products and industries where similar solutions have already been explored.
  • Technology Developer Scan: Identified companies actively engaged in developing such solutions.
  • Patent & Literature Review: Analyzed patents and academic publications to capture early-stage innovations.

Evaluated each identified technology for its potential applicability in the client’s product portfolio and assessed the feasibility of proposed solutions.

Value Delivered

Recommended a final selection of five preferred target companies for the client’s consideration, based on:

  • Attractiveness of the opportunity.
  • Fit with the client’s infrastructure and objectives.

Each shortlisted opportunity represented a distinct strategic focus (geography, end-use segment, or technology).

Included a proposal for a game-changing merger with the potential to transform the competitive landscape in this domain.

Geographies of Interest: Global

Management Challenge

The client was interested in scouting technologies related to non-organic solvents with potential applications across multiple industries, particularly in paper and pulp processing. The objective was to evaluate the current technical solutions and assess their applicability in future product offerings.

Approach

Secondary Research

  • Scanned diverse resources including technology blogs, scientific literature, patents, technology magazines, company reports, R&D blogs, start-up assessments, academic publications, and crowdfunding/innovation portals.

Consulting Partner Collaboration

  • Worked closely with consulting partners to identify and scout technologies of interest.
  • Shortlisted technologies at nascent stages from start-ups and universities.
  • Compiled a consolidated technology pool for evaluation.

Primary Research & Validation

  • Analyzed insights from secondary research and validated findings with industry experts.
  • Conducted in-depth consultations and interviews with KOLs to extract key trends and opportunities.

Benchmarking & Scoring

  • Applied Matiim’s in-house benchmarking framework to map and assess technologies across multiple parameters.
  • Identified and ranked best-in-class technologies for client consideration.

Value Delivered

  • Delivered a comprehensive technology due diligence analysis to the client’s R&D team.
  • Enabled the client to understand the most relevant technology areas and players in non-organic solvents.
  • Provided visibility on the status of technology development and the investment landscape, supporting informed decision-making for future product strategies.
Geographies of Interest: India

Management Challenge

A leading Korean telecom and communication equipment supplier planned to expand into India. However, it faced uncertainties around:

  • Complex regulatory framework (DoT, TRAI, WPC, BIS, TEC certifications).
  • Evolving compliance norms related to spectrum usage, data privacy, and equipment security.
  • High risk of delays and penalties if approvals were mishandled.

Approach

Matiim conducted 10+ interviews with major stakeholders in India to understand the possible scenarios under the following bullets.

  • Regulatory Mapping: Analyzed all applicable Indian telecom, wireless, and equipment approval requirements.
  • Benchmarking: Compared compliance pathways of foreign players who had successfully entered India.
  • Stakeholder Engagement: Conducted interviews with ex-regulators, certification experts, and local industry associations.

Roadmap Design: Built a step-by-step compliance and approval timeline, highlighting potential bottlenecks.

Value Delivered

Clarity on Compliance: Delivered a comprehensive guide on mandatory certifications, timelines, and documentation.

Risk Mitigation: Identified potential regulatory hurdles early, reducing approval delays.

Market Entry Acceleration: Enabled the client to prepare submissions proactively and align with Indian authorities.

Strategic Advantage: Positioned the supplier as a compliance-ready entrant, improving credibility with Indian partners and telecom operators

Geographies of Interest: India Korea and Japan

Management Challenge

A leading European bulk SMS service provider sought to expand into high-growth Asian markets. Key challenges included:

  • Market Dynamics: Highly fragmented markets dominated by local aggregators and telecom operators.
  • Pricing Pressure: Extremely competitive and regulated SMS pricing in India, premium costs in Japan, and carrier-driven margins in Korea.
  • Regulatory Complexity: Stringent telecom compliance requirements (TRAI in India, KISA in Korea, MIC in Japan).
  • Customer Expectations: Demand for multi-channel integration (SMS, RCS, WhatsApp, LINE, KakaoTalk) beyond traditional bulk messaging.

Approach

  • Market Assessment: Analyzed SMS and A2P (Application-to-Person) messaging trends, pricing structures, and telecom regulations in India, Korea, and Japan.
  • Competitive Benchmarking: Compared offerings of local players and global CPaaS providers, identifying differentiation opportunities in reliability, security, and analytics.
  • Regulatory Mapping: Built a compliance roadmap for each country, aligning with local telecom norms and data privacy laws.
  • Stakeholder Insights: Conducted interviews with enterprises (banks, e-commerce, travel, gaming) to understand adoption drivers and volume commitments.
  • Pricing Strategy: Recommended country-specific models—low-cost/high-volume in India, enterprise-focused in Japan, and partnership-led in Korea.

Value Delivered

Market Entry Roadmap: Provided a phased expansion strategy, starting with high-volume Indian enterprises, followed by strategic partnerships in Korea and Japan.

Differentiated Positioning: Positioned client as a secure, analytics-driven messaging partner rather than a pure SMS vendor.

Revenue Opportunities: Identified top enterprise sectors (banking, fintech, e-commerce, travel) with strong A2P adoption potential.

Commercial Impact: Enabled client to secure initial contracts in India and partnership discussions with Korean carriers, creating a scalable growth model across Asia.

Geographies of Interest: China

Management Challenge

The client, a leading multi-level marketing company, wanted insights on how target competitors approached specific topics across different city tiers in China. The client provided a list of six competitors and sought to assess the following through a primary research exercise:

  • Entry strategy for the target companies.
  • Differences in entry and ongoing business support between Tier 1–2 cities and Tier 3–5 cities.
  • Target customers/distributors (counselors).
  • Marketing and advertising activities.
  • Sales and support activities.
  • Digital/online presence and support.
  • Physical presence (brick-and-mortar).
  • Supply chain strategies.

Approach

Respondent Segmentation: Divided respondents into two groups:

(a) Corporate: Senior Manager or above.

(b) Distributor/Counselor: Minimum of 5 years’ association with the target company.

Discussion Guides: Developed tailored discussion guides for each respondent group in consultation with the client.

Fieldwork Execution: Scheduled and conducted face-to-face and telephonic interviews with company personnel and counselors.

Language Adaptation: Carried out interviews in Mandarin or English, with transcripts translated into English for reporting.

Sample Size: Completed 30 in-depth interviews (5 per company: 3 corporate, 2 counselors) over a period of 5 weeks.

Value Delivered

  • Provided insights into the types of customers targeted across Tier 1–2 versus Tier 3–5 cities.
  • Clarified differences in customer behavior between top-tier and lower-tier cities.
  • Identified tactics used by competitors to raise awareness across different city tiers.
  • Quantified the percentage of sales contribution from Tier 1–2 versus Tier 3–5 cities.
  • Highlighted the digital channels and support mechanisms used by competitors to engage distributors and customers.
Geographies of Interest: Asia Pacific

Management Challenge

A leading US-based management consulting firm engaged Matiim to conduct a comprehensive competitive benchmarking study across six Asian markets. The client aimed to gain deeper visibility into its competitive positioning and identify strategic opportunities relative to four pre-identified rival firms.

The specific objectives were to evaluate competitors on:

  • Firm alignment (strategic focus, organizational structure, and regional presence)
  • Strengths and weaknesses across service lines
  • Revenue and growth performance over the last 2–3 years
  • Future growth priorities over the next 1–3 years
  • Market perception and reputation among clients and industry stakeholders

Approach

Matiim designed a multi-source intelligence framework combining both secondary and primary research:

Secondary Research:

  • Reviewed press releases, corporate announcements, and media coverage across multiple Asian markets.
  • Analyzed annual reports, investor presentations, and financial disclosures.
  • Monitored social media activity and thought leadership publications.
  • Assessed regional language sources to ensure localized insights.

Primary Research:

  • Conducted telephone-based interviews with industry experts, former employees, and local stakeholders.
  • Captured nuanced intelligence on service delivery models, client relationships, and competitor positioning.

Analysis & Synthesis:

  • Benchmarked competitors across service offerings, sector focus, talent models, and client engagement strategies.
  • Identified patterns of investment, geographic expansion, and partnership models that signaled near-term growth priorities.

Value Delivered

Strategic Insights: Delivered detailed competitor profiles, highlighting revenue performance, market positioning, and differentiation strategies.

Growth Priorities: Identified service areas and geographies where competitors were investing most heavily, providing foresight into future competitive threats.

Market Perception: Mapped stakeholder opinions on reputation, service quality, and brand equity, allowing the client to benchmark its own standing.

Decision Support: Equipped the client with actionable intelligence to refine its go-to-market strategy, identify competitive white spaces, and prioritize future investments.

Impact: The study provided the client with a clear, data-driven view of the competitive landscape, strengthening its ability to anticipate competitor moves, position its services effectively, and sharpen its growth strategy in Asia. The engagement was highly valued, and the client expressed satisfaction with the depth, accuracy, and strategic relevance of the insights delivered.

Geographies of Interest: Germany

Management Challenge

A multinational financial services firm sought to evaluate entry into the German P&C insurance market, requiring insights on growth drivers, product segments, regulations, and competitor positioning.

Approach

  • Conducted secondary research (industry reports, databases, regulatory sources).
  • Ran primary interviews with brokers, insurers, and experts.
  • Analyzed market size, forecasts, and competitive dynamics (Allianz, AXA, Zurich, R+V).
  • Assessed regulatory changes and underwriting implications.

Value Delivered

  • 5-year market outlook with growth forecasts by segment.
  • Identified attractive non-life product opportunities.
  • Benchmarking of key incumbents’ portfolios and strategies.
  • Actionable recommendations for expansion pathways and partnerships.
  • Impact: Enabled the client to make data-driven market entry decisions with clear visibility on demand, competition, and regulatory risks.
Geographies of Interest: Europe

Management Challenge

A leading navigation technology provider sought to monetize its innovations by licensing them to European automobile manufacturers. While its technology was widely recognized for accuracy and advanced features (real-time traffic, predictive routing, voice-enabled AI integration), the company faced key hurdles:

  • Highly competitive EU automotive market dominated by OEMs preferring in-house or long-term tech partners.
  • Fragmented regulatory and data-privacy landscape (e.g., GDPR compliance, mapping data ownership).
  • Complex negotiation dynamics with top-tier OEMs and Tier-1 suppliers who demanded exclusivity and cost efficiency.
  • Need for differentiation against established players such as HERE, TomTom, and Google Automotive Services.

Approach

  • Matiim Analytics conducted a multi-layered competitive and market-intelligence study to support the out-licensing strategy:
  • Market Mapping: Assessed adoption of third-party navigation technologies across leading OEMs in EU5, identifying target partners most open to licensing vs. in-house development.
  • Competitive Benchmarking: Compared features, pricing, and licensing models of rival navigation providers, highlighting differentiators such as AI-driven personalization and EV-specific routing.
  • Regulatory Assessment: Evaluated compliance requirements under EU mobility, data-sharing, and privacy directives, ensuring the technology was positioned as “GDPR-safe.”
  • Stakeholder Interviews: Engaged with OEM innovation leads, Tier-1 integrators, and telematics experts to understand purchasing drivers, barriers, and preferred engagement models.
  • Deal Structuring Support: Recommended flexible licensing models (royalty-based, per-unit pricing, and revenue-share for connected services) to align with diverse OEM needs.

Value Delivered

Strategic Positioning: Helped the client reposition its technology not just as a navigation system, but as a connected mobility enabler (integrated EV routing, over-the-air updates, predictive safety alerts).

Pipeline of Prospects: Identified and prioritized 10+ EU OEMs and Tier-1 suppliers with immediate licensing potential.

Regulatory Confidence: Delivered a compliance roadmap, reducing perceived risk for OEMs and strengthening negotiation leverage.

Commercial Outcomes: Enabled the client to secure two multi-year licensing agreements with EU carmakers, projected to generate double-digit revenue growth within three years.

Differentiation: Positioned the client as a specialized alternative to Google Automotive Services, leveraging local data sovereignty and customizability—key concerns for European partners.

matiim

The next insight

connect@matiim.com

Linkedin X-twitter

www.matiim.com

Quick Links

Offerings & Capabilities

Case Studies

Team

Careers

Contact Us

Copyright @ Verumque Research and Consulting Private Limited

CIN Number: U74999UP2017PTC090565

Home

Offerings & Capabilities

Global Network

Credentials

Case Studies

Team

Careers

Contact Us

Linkedin X-twitter